Corrected Proof scheduled for 27 (4)

Risk Factors of Retinopathy of Prematurity Associated with Delayed Retinal Vascular Development

Authors Information
Article Notes and Dates
To Cite : Ortega-Molina JM. , de Larraya A. S, A. S, A. J, J. U, et al. Risk Factors of Retinopathy of Prematurity Associated with Delayed Retinal Vascular Development, Iran J Pediatr. Online ahead of Print ;In Press(In Press):e7642. doi: 10.5812/ijp.7642.
Abstract
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Hwang JH, Lee EH, Kim EA. Retinopathy of Prematurity among Very-Low-Birth-Weight Infants in Korea: Incidence, Treatment, and Risk Factors. J Korean Med Sci. 2015; 30 Suppl 1-94[DOI][PubMed]
  • 2. Poets CF, Roberts RS, Schmidt B, Whyte RK, Asztalos EV, Bader D, et al. Association Between Intermittent Hypoxemia or Bradycardia and Late Death or Disability in Extremely Preterm Infants. JAMA. 2015; 314(6): 595-603[DOI][PubMed]
  • 3. Hellstrom A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013; 382(9902): 1445-57[DOI][PubMed]
  • 4. Hartnett ME. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology. 2015; 122(1): 200-10[DOI][PubMed]
  • 5. Garcia-Serrano JL, Ramirez-Garcia MC, Pinar-Molina R. [Retinopathy of prematurity in multiple births: risk analysis for plus disease]. Arch Soc Esp Oftalmol. 2009; 84(4): 191-8[PubMed]
  • 6. Ghaseminejad A, Niknafs P. Distribution of retinopathy of prematurity and its risk factors. Iran J Pediatr. 2011; 21(2): 209-14[PubMed]
  • 7. Sato T, Kusaka S, Shimojo H, Fujikado T. Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity. Ophthalmology. 2009; 116(11): 2165-9[DOI][PubMed]
  • 8. Can E, Bulbul A, Uslu S, Bolat F, Comert S, Nuhoglu A. Early Aggressive Parenteral Nutrition Induced High Insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 3 (IGFBP3) Levels Can Prevent Risk of Retinopathy of Prematurity. Iran J Pediatr. 2013; 23(4): 403-10[PubMed]
  • 9. Sapieha P, Joyal JS, Rivera JC, Kermorvant-Duchemin E, Sennlaub F, Hardy P, et al. Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life. J Clin Invest. 2010; 120(9): 3022-32[DOI][PubMed]
  • 10. Cavallaro G, Filippi L, Bagnoli P, La Marca G, Cristofori G, Raffaeli G, et al. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol. 2014; 92(1): 2-20[DOI][PubMed]
  • 11. Chen J, Stahl A, Hellstrom A, Smith LE. Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr. 2011; 23(2): 173-8[DOI][PubMed]
  • 12. He JH, Zhang J. Fifth dimension of life and the 4/5 allometric scaling law for human brain. Cell Biol Int. 2004; 28(11): 809-15[DOI][PubMed]
  • 13. Lofqvist C, Engstrom E, Sigurdsson J, Hard AL, Niklasson A, Ewald U, et al. Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit. Pediatrics. 2006; 117(6): 1930-8[DOI][PubMed]
  • 14. Downie LE, Hatzopoulos KM, Pianta MJ, Vingrys AJ, Wilkinson-Berka JL, Kalloniatis M, et al. Angiotensin type-1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity. J Comp Neurol. 2010; 518(1): 41-63[DOI][PubMed]
  • 15. Ferrer Novella C, Gonzalez Viejo I, Pueyo Royo V, Martinez Fernandez R, Galdos Iztueta M, Peralta Calvo J, et al. [A protocol for the treatment of retinopathy of prematurity in Spain]. Arch Soc Esp Oftalmol. 2013; 88(6): 231-6[DOI][PubMed]
  • 16. Ferrer Novella C, Gonzalez Viejo I, Pueyo Royo V, Martinez Fernandez R, Galdos Iztueta M, Peralta Calvo J, et al. Screening program for retinopathy of prematurity in Spain. Arch Soc Esp Oftalmol. 2013; 88(5): 184-8[DOI][PubMed]
  • 17. Ortega-Molina JM, Anaya-Alaminos R, Uberos-Fernandez J, Solans-Perez de Larraya A, Chaves-Samaniego MJ, Salgado-Miranda A, et al. Genetic and Environmental Influences on Retinopathy of Prematurity. Mediators Inflamm. 2015; 2015: 764159[DOI][PubMed]
  • 18. Hillman SC, Morris RK, Kilby MD. Single twin demise: consequence for survivors. Semin Fetal Neonatal Med. 2010; 15(6): 319-26[DOI][PubMed]
  • 19. Barba J S, Carvajal C J. Pautas de manejo del embarazo múltiple complicado con la muerte fetal in útero de un gemelo. Revista chilena de obstetricia y ginecología. 2012; 77(2): 159-68[DOI]
  • 20. Eichenwald EC, Committee on F, Newborn AAOP. Apnea of Prematurity. Pediatrics. 2016; 137(1)[DOI][PubMed]
  • 21. Wade KC, Pistilli M, Baumritter A, Karp K, Gong A, Kemper AR, et al. Safety of Retinopathy of Prematurity Examination and Imaging in Premature Infants. J Pediatr. 2015; 167(5): 994-1000 e2[DOI][PubMed]
  • 22. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006; 114(17): 1873-82[DOI][PubMed]
  • 23. Golombek SG, Sola A, Baquero H, Borbonet D, Cabanas F, Fajardo C, et al. [First SIBEN clinical consensus: diagnostic and therapeutic approach to patent ductus arteriosus in premature newborns]. An Pediatr (Barc). 2008; 69(5): 454-81[PubMed]
  • 24. Gonzalez Viejo I, Ferrer Novella C, Pueyo Royo V, Garcia Martin E, Rite Gracia S, Caballero Perez V, et al. [Is patent ductus arteriosus a risk factor for retinopathy of prematurity?]. An Pediatr (Barc). 2011; 74(1): 25-30[DOI][PubMed]
  • 25. Goswami B, Goyal M, Beri S, Garg R, Saili A, Jain A. Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity. Iran J Pediatr. 2015; 25(4)[DOI][PubMed]
  • 26. Panfoli I, Cassanello M, Bruschettini M, Colella M, Cerone R, Ravera S, et al. Why do premature newborn infants display elevated blood adenosine levels? Med Hypotheses. 2016; 90: 53-6[DOI][PubMed]
  • 27. International Committee for the Classification of Retinopathy of P. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005; 123(7): 991-9[DOI][PubMed]
  • 28. Chiang MF, Thyparampil PJ, Rabinowitz D. Interexpert agreement in the identification of macular location in infants at risk for retinopathy of prematurity. Arch Ophthalmol. 2010; 128(9): 1153-9[DOI][PubMed]
  • 29. Ngo MH, Borowska-Fielding J, Heathcote G, Nejat S, Kelly ME, McMaster CR, et al. Fzd4 Haploinsufficiency Delays Retinal Revascularization in the Mouse Model of Oxygen Induced Retinopathy. PLoS One. 2016; 11(8)[DOI][PubMed]
  • 30. Anaya-Alaminos R, Garcia-Serrano JL, Cantero-Hinojosa J. Prenatal and postnatal factors increase risk of severe ROP. J Matern Fetal Neonatal Med. 2014; 27(6): 635-6[DOI][PubMed]
  • 31. Lajko M, Cardona HJ, Taylor JM, Shah RS, Farrow KN, Fawzi AA. Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption. PLoS One. 2016; 11(11)[DOI][PubMed]
  • 32. Klevebro S, Lundgren P, Hammar U, Smith LE, Bottai M, Domellof M, et al. Cohort study of growth patterns by gestational age in preterm infants developing morbidity. BMJ Open. 2016; 6(11)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Iranian Journal of Pediatrics accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check